drugset / Trial / NCT01586169
Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination
Completed
3000 enrolled
Centre d'Appui à la lutte contre la Maladie
International Trachoma Initiative · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the triple co administration of albendazole, ivermectin and azithromycine is as safe as the current treatment scheme that consists to treat with albendazole plus ivermectin together and a week later to treat with azithromycin in areas co endemic for lymphatic filariasis and trachoma.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albendazole | Small molecule | 400 mg | — |
| Subject | Azithromycin | Small molecule | — | — |
| Subject | Ivermectin | Small molecule | — | — |